Lovisa Holdings (LOV.AX)

Overall impact
D (21)

Commentary

Lovisa Holdings is a below-average overall performer. With a 'D' rating of 20.9 for overall impact (bottom 10% of all companies), Lovisa Holdings ranks 118th out of 119 industry peers, behind Salvatore Ferragamo, Madewell, Scoop-Storecode Texteis and 114 others, and ahead of Spanx. On top material causes for Lovisa Holdings's industry (Textiles, Apparel & Luxury Goods), Lovisa Holdings performs poorly in Sustainable Use of Water (30.5 score), Fair Labor Practices (0.0), Accountable Institutions (32.5) and 70 other causes where it received a 'D' or 'F' score. Lovisa Holdings did not receive an 'A' rating on any cause.
Screens
Fur
Impact
Cause LOV.AX
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
8,000
Sector
Consumer Discretionary
Industry
Textiles, Apparel & Luxury Goods
Sub-industry
Apparel, Accessories & Luxury Goods
SASB industry
Household & Personal Products
Headquarters
Vic, Australia
Share classes
LOV.AX
Description
Lovisa Holdings Limited engages in the retail sale of fashion jewelry and accessories. It designs, develops, sources, and merchandises fashion jewelry and accessories under the Lovisa brand name. The company also retails its products online. It operated its retail and franchise stores in Australia, New Zealand, Singapore, Malaysia, Hong Kong, Taiwan, Vietnam, China, South Africa, Botswana, Namibia, the United Arab Emirates, the United States, Canada, Mexico, the United Kingdom, Spain, France, Luxembourg, Belgium, Germany, the Netherlands, Austria, Switzerland, Poland, Italy, Hungary, Romania, Ireland, South America, and the Middle East. Lovisa Holdings Limited was founded in 2010 and is based in Hawthorn, Australia.
Material causes
Ethos considers the following causes material for Lovisa Holdings, based on its industry sub-industry Apparel, Accessories & Luxury Goods. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.